Published in PLoS One on October 20, 2009
Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem (2010) 1.89
Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat Commun (2012) 1.41
Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting. PLoS Pathog (2011) 1.16
Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Res (2011) 1.09
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc Natl Acad Sci U S A (2012) 1.00
Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase. Antimicrob Agents Chemother (2010) 0.99
Cross-species analysis of the replication complex of Old World arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol (2011) 0.96
Limited compatibility of polymerase subunit interactions in influenza A and B viruses. J Biol Chem (2010) 0.91
Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences. J Virol (2011) 0.86
Conserved features of the PB2 627 domain impact influenza virus polymerase function and replication. J Virol (2014) 0.84
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex. Virol J (2014) 0.82
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. Med Res Rev (2016) 0.80
Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets. Sci Rep (2015) 0.80
Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus. J Biol Chem (2010) 0.80
Crucial role of PA in virus life cycle and host adaptation of influenza A virus. Med Microbiol Immunol (2014) 0.80
Perspective of Use of Antiviral Peptides against Influenza Virus. Viruses (2015) 0.79
Nuclear localization of influenza B polymerase proteins and their binary complexes. Virus Res (2011) 0.78
Integrating computational modeling and functional assays to decipher the structure-function relationship of influenza virus PB1 protein. Sci Rep (2014) 0.77
Application of a split luciferase complementation assay for the detection of viral protein-protein interactions. J Virol Methods (2011) 0.77
A comparative study of short linear motif compositions of the influenza A virus ribonucleoproteins. PLoS One (2012) 0.76
Screening for novel small molecule inhibitors targeting the assembling of influenza virus polymerase complex by a BiLC-based reporter system. J Virol (2016) 0.75
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
Neuraminidase inhibitors for influenza. N Engl J Med (2005) 7.79
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). Science (1964) 6.72
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA (2009) 5.84
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature (2009) 4.49
Global transmission of oseltamivir-resistant influenza. N Engl J Med (2009) 4.34
The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol (2008) 4.33
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis (1998) 3.47
A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol (2002) 3.37
Antiviral agents active against influenza A viruses. Nat Rev Drug Discov (2006) 3.12
Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature (2008) 3.06
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature (2008) 2.74
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog (2009) 2.23
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell (2007) 2.22
Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem (2003) 2.15
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A (2002) 2.11
The evolutionary dynamics of human influenza B virus. J Mol Evol (2008) 1.84
Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity. J Virol (2001) 1.82
Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J (2009) 1.78
The influenza A virus PB2 polymerase subunit is required for the replication of viral RNA. J Virol (1997) 1.71
Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology (1987) 1.68
The RNA polymerase of influenza a virus is stabilized by interaction with its viral RNA promoter. J Virol (2002) 1.66
Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol (1979) 1.65
Small-molecule inhibitors of protein-protein interactions. Curr Opin Drug Discov Devel (2008) 1.63
Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer. Nucleic Acids Res (2007) 1.62
A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J (2005) 1.55
A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J Virol (1995) 1.52
Resurrected pandemic influenza viruses. Annu Rev Microbiol (2009) 1.50
Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci U S A (2000) 1.49
Peptide-mediated interference with influenza A virus polymerase. J Virol (2007) 1.48
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J Virol Methods (2001) 1.35
Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology (1995) 1.34
Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling. Chem Biol (2008) 1.30
Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J Virol (2003) 1.27
Severe illness with influenza B. Am J Med (1980) 1.27
The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology (1997) 1.22
Inhibitors of cell migration that inhibit intracellular paxillin/alpha4 binding: a well-documented use of positional scanning libraries. Chem Biol (2002) 1.04
Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication. Chem Biol (2004) 1.03
Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control. J Infect Dis (1980) 0.99
Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction. J Biol Chem (2003) 0.88
Limited compatibility between the RNA polymerase components of influenza virus type A and B. Virus Res (2008) 0.86
An influenza B epidemic within a remote Alaska community. Serologic, epidemiologic, and clinical observations. JAMA (1970) 0.85
Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst (2009) 3.45
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem (2004) 2.29
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res (2007) 2.21
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell (2008) 2.12
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe (2009) 2.01
Activation of a vinculin-binding site in the talin rod involves rearrangement of a five-helix bundle. EMBO J (2004) 1.73
Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol (2003) 1.72
Mapping and consensus sequence identification for multiple vinculin binding sites within the talin rod. J Biol Chem (2005) 1.68
The Rho-associated protein kinase p160ROCK is required for centrosome positioning. J Cell Biol (2002) 1.65
Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A (2005) 1.61
A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol Microbiol (2002) 1.52
The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol (2011) 1.51
Peptide-mediated interference with influenza A virus polymerase. J Virol (2007) 1.48
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J (2006) 1.45
Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol (2002) 1.42
Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology (2008) 1.41
Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat Commun (2012) 1.41
Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J Virol (2003) 1.40
Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J Virol (2013) 1.40
Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J Virol (2003) 1.27
PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J Biol Chem (2004) 1.25
Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog (2013) 1.24
Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem (2003) 1.23
Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio (2011) 1.22
Borna disease virus interference with neuronal plasticity. Virus Res (2005) 1.19
Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting. PLoS Pathog (2011) 1.16
Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. Angew Chem Int Ed Engl (2010) 1.13
Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity. Antiviral Res (2010) 1.12
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
Inference of genetic regulatory networks with recurrent neural network models using particle swarm optimization. IEEE/ACM Trans Comput Biol Bioinform (2007) 1.11
Minimum information about a protein affinity reagent (MIAPAR). Nat Biotechnol (2010) 1.10
Taxonomic reorganization of the family Bornaviridae. Arch Virol (2014) 1.09
Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing. RNA (2006) 1.09
High-avidity human serum antibodies recognizing linear epitopes of Borna disease virus proteins. Biol Psychiatry (2002) 1.08
Molecular and functional characterization of clathrin- and AP-2-binding determinants within a disordered domain of auxilin. J Biol Chem (2003) 1.08
The granulocyte receptor carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) directly associates with Vav to promote phagocytosis of human pathogens. J Immunol (2007) 1.06
Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine. Infect Immun (2007) 1.04
Bornavirus closely associates and segregates with host chromosomes to ensure persistent intranuclear infection. Cell Host Microbe (2012) 1.03
Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J Virol (2011) 1.03
Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation. Mol Pharmacol (2004) 1.02
The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters. J Virol (2009) 1.01
Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J Gen Virol (2010) 1.01
Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. Microbiology (2006) 1.00
Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J Biol Chem (2004) 0.99
14-3-3 proteins are constituents of the insoluble glycoprotein framework of the chlamydomonas cell wall. Plant Cell (2003) 0.99
A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J Virol (2010) 0.99
Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase. Antimicrob Agents Chemother (2010) 0.99
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One (2009) 0.98
An RGD helper sequence in CagL of Helicobacter pylori assists in interactions with integrins and injection of CagA. Front Cell Infect Microbiol (2012) 0.98
The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol (2011) 0.98
Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1alpha. Mol Biol Cell (2006) 0.97
N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol (2010) 0.97
Neurofilaments bind tubulin and modulate its polymerization. J Neurosci (2009) 0.96
Identification and characterization of the Cdc42-binding site of IQGAP1. Biochem Biophys Res Commun (2003) 0.94
Systematic delineation of a calmodulin peptide interaction. J Mol Biol (2004) 0.94
Protocadherin 12 (VE-cadherin 2) is expressed in endothelial, trophoblast, and mesangial cells. Exp Cell Res (2005) 0.94
Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex. J Biol Chem (2004) 0.92
MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism. FASEB J (2010) 0.92
Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity. J Virol (2006) 0.92
WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta. FEBS J (2007) 0.91
Limited compatibility of polymerase subunit interactions in influenza A and B viruses. J Biol Chem (2010) 0.91
Profiling ubiquitin linkage specificities of deubiquitinating enzymes with branched ubiquitin isopeptide probes. Chembiochem (2012) 0.91
Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J Virol Methods (2005) 0.90
Functional characterization of the major and minor phosphorylation sites of the P protein of Borna disease virus. J Virol (2007) 0.89
A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico. Virol J (2013) 0.89
Phosphatidylinositol 3'-kinase activity is critical for initiating the oxidative burst and bacterial destruction during CEACAM3-mediated phagocytosis. J Biol Chem (2011) 0.88
Peptide-mediated disruption of NFkappaB/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori. J Immunol (2007) 0.88
Borna disease virus replication in organotypic hippocampal slice cultures from rats results in selective damage of dentate granule cells. J Virol (2005) 0.88
Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept. Mol Divers (2009) 0.87
Isolation of viral ribonucleoprotein complexes from infected cells by tandem affinity purification. Proteomics (2005) 0.87
Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions. Methods (2011) 0.87
The EAL-like protein STM1697 regulates virulence phenotypes, motility and biofilm formation in Salmonella typhimurium. Mol Microbiol (2013) 0.86